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Abstract Gastrojejunostomy stricture after Roux-en-Y gastric bypass occurs in 3 to 27% of morbidly obese patients in the
USA. We questioned whether preoperative patient characteristics, including demographic attributes and comorbid disease,
might be significant factors in the etiology of stricture. In this study from November 2001 to February 2006 (51 months), at
a high-volume bariatric center, of the 1,351 patients who underwent laparoscopic gastric bypass, 92 developed stricture
(6.8%). All but two were treated successfully by endoscopic dilation. All patients stopped nonsteroidal anti-inflammatory
medications 2 weeks prior to surgery and did not restart them. The operative procedure included the use of a 21-mm
transoral circular stapler to create the gastrojejunostomy; the Roux limb was brought retrogastric, retrocolic. In an effort to
reduce our center’s stricture rate, late in the study, U-clips used at the gastrojejunostomy were replaced by absorbable
sutures, and postoperative H2 antagonists were added to the treatment protocol. The change to absorbable polyglactin suture
proved to be significant, resulting in a lower stricture rate. The addition of H2 antagonists showed no significant effect.
Following the retrospective review of the prospective database, univariate and multivariate logistic regression analyses
identified factors associated with the development of stricture. Gastroesophageal reflux disease and age were each shown to
be statistically significant independent predictors of stricture following laparoscopic gastric bypass.
Keywords Obesity.Bariatricsurgery.Stricture.Gastric
bypass.Gastrojejunostomy
Introduction
Bariatric surgery, particularly Roux-en-Y gastric bypass
(RYGB), has been proven safe
1,2 and effective in achieving
long-term weight loss,
3,4 comorbidity reduction,
3,5 and
enhancement of quality of life.
6 Since its introduction by
Wittgrove et al. in 1994,
7 laparoscopic Roux-en-Y gastric
bypass (LRYGB) has been shown to be as reliable as open
RYGB
8–10 and less traumatic, requiring a briefer recovery
time and shorter duration of stay.
11 It is effective in
achieving comparable weight loss at 1 year
3,12–15 and is
successful in reducing the comorbidities of morbid obesi-
ty.
3,9,13 Laparoscopic RYGB has surpassed other weight-
loss methods for the morbidly obese in frequency of use in
the USA.
14
Laparoscopic RYGB is a technically demanding proce-
dure with a lengthy learning curve of approximately 100
cases.
16,17 Gastrojejunostomy stricture following RYGB
has been reported variously in 3 to 27% of patients.
12,16–19
Actual incidence of this complication is a function of the
accuracy of its diagnosis and reporting
19 and has been
shown to be relative to operative technique and surgeon
experience.
20 Other known etiologies of stricture following
LRYGB are tension on the anastomosis, foreign body
reaction, technical error in creation of the anastomosis,
marginal ulcer, and leak with associated scarring.
19
In 2003, Perugini and colleagues published an analysis
of preoperative predictors of complications.
20 They
reported a 14.4% rate of gastrojejunostomy stricture (N=
27/188), greater than half of all complications. With
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found that surgeon experience was the most significant
predictor of complications in general (not of stricture
specifically) and that sleep apnea and hypertension were
also significant independent predictors of complications.
20
Perugini et al. cautioned that the factors they identified
(experience, sleep apnea, hypertension) as predictive of
complications in general might, in fact, “ be specific for the
complication of gastrojejunal stenosis”.
20 Our study took up
this question and, by univariate and multivariate logistic
regression, analyzed preoperative predictors specifically for
stricture.
Patients and Methods
Patients
A consecutive series of morbidly obese patients underwent
LRYGB between November 12, 2001, and February 28,
2006 (51 months), in a dedicated, community-based,
bariatric program awarded Center-of-Excellence status by
the Surgical Review Corporation in 2005.
Institutional review board approval and informed con-
sent were obtained prior to prospective data collection. In a
retrospective analysis, preoperative patient characteristics,
including whether the patient was taking any nonsteroidal
anti-inflammatory medications on a chronic basis prior to
surgery, were compared for two groups: those who
developed gastrojejunostomy stricture (N=17/92, 6.8%)
and those who did not (N=311/1,259, 93.2%). No patients
were excluded from the study.
Patients where tested for Helicobacter pylori and treated
if positive. Anti-inflammatory medications were withheld
2 weeks preoperatively and not resumed postoperatively.
Procedures were performed by four bariatric surgeons.
Stenosis, or stricture, indicated by progressive dysphagia,
nausea, and vomiting, was diagnosed by endoscopy.
Surgical Technique
The procedure was performed using the transoral end-to-
end anastomotic (EEA) technique similar to the Wittgrove
technique.
10 Using a Veress needle to an intra-abdominal
pressure of 15 mm Hg, abdominal insufflation was
performed. The patient was placed supine, in the reverse
Table 1 Univariate Analysis to Identify Preoperative Patient Characteristics Associated with Stricture
Variable Stricture Group [N (%)] Nonstricture Group [N (%)] P Value
No. patients (N=1,351) 92 1,259
Age, mean (SD) 41.4 (11.6) 44.4 (10.4) 0.039
a
Cardiac disease 6 (6.5) 107 (8.5) 0.885
Chronic depression 21 (22.8) 278 (22.1) 0.634
Chronic respiratory disease 22 (23.9) 318 (25.3) 0.766
Chronic venous insufficiency 53 (57.6) 692 (55.0) 0.347
Degenerative joint disease 89 (96.7) 1,209 (96.0) 0.893
Diabetes, type 2 26 (28.3) 307 (24.4) 0.184
Ethnicity, N (%) –– 0.145
Caucasian 76 (82.6) 1,122 (89.1) –
Other 16 (17.4) 137 (10.9) –
GERD 66 (71.7) 715 (56.8) 0.035
a
Sex, N (%) –– 0.208
Female 81 (88.0) 1,042 (82.8) –
Male 11 (12.0) 217 (17.2) –
Hypercholesterolemia/hyperlipidemia 40 (43.5) 624 (49.6) 0.958
Hypertension 41 (44.6) 652 (51.8) 0.838
Infertility 11 (12.0) 96 (7.6) 0.732
Nonsteroidal anti-inflammatory medications 17 (18.5) 294 (23.4) 0.284
No. preoperative comorbidities 5.2 (2.0) 5.1 (1.9) 0.259
No. preoperative medications 4.6 (3.6) 4.2 (3.5) 0.088
Obstructive sleep apnea 43 (46.7) 564 (44.8) 0.415
BMI 48.5 (8.5) 49.2 (8.3) 0.202
Fasting blood sugar 111.5 (45.4) 108.9 (39.6) 0.779
HbA1C 6.2 (1.8) 6.1 (1.2) 0.150
Previous abdominal surgeries 1.2 (1.1) 1.2 (1.3) 0.754
Urinary stress incontinence 52 (56.5) 698 (55.4) 0.322
aSignificance at the 0.05 level
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introduced. The angle of His was dissected, and a 15-ml
balloon was passed transorally and placed at the esoph-
agogastric junction. The lesser sac was entered just below
the balloon on the lesser curve of the stomach. A 15- to 20-
ml gastric pouch was created with the Endo GIA 45-mm
stapler (Ethicon Endo-Surgery, Cincinnati, OH, USA),
using an average of three firings. A guidewire was
introduced through the anterior abdominal wall and an
endoscope was passed transorally. Cautery was used to pass
the snare through the pouch and grasp the guidewire. The
anvil of the 21-mm EEA Stealth stapler (Ethicon Endo-
Surgery) was attached to the guidewire and brought down
through the mouth. The ligament of Treitz was identified,
and, approximately 20 cm distally, the jejunum was
divided. A 100-cm Roux limb was created for patients
with BMI<55 kg/m
2, and a 150-cm Roux limb was created
for patients with BMI≥55 kg/m
2. The jejunojejunostomy
was stapled side to side, and closed with the Endo GIA
stapler. The Roux limb was brought retrocolic, retrogastric
through the lesser curve of the stomach. The EEA circular
stapler was introduced through the abdominal wall and the
gastrojejunostomy was stapled end to end. The posterior
wall of the gastrojejuostomy lays on soft tissue that holds
the left gastric and vagus nerve and does not need
reinforcement. All techniques for reinforcing the gastro-
jejunostomy were instituted only in the anterior wall of the
anastamosis as a second layer. The initial technique was to
sew a continuous second layer of the gastrojejunostomy
anteriorly with 3–0 polyglactin absorbable suture. The
angle is often technically demanding. In October 2005, the
procedure was modified to one in which the gastro-
jejunostomy was oversewn with two Nitinol “U” clips that
revert to preformed circular memory when placed, without
additional suture. In October of 2005, these U-clips were
replaced with two interrupted 3–0 polyglactin absorbable
sutures. Finally, in January 2006, the addition of H2
antagonists for 90 days to the postoperative regimen was
made. These technical changes were instituted in an attempt
to lessen the stricture rate, which is followed monthly in our
database.
Patients who experienced persistent postoperative nau-
sea, vomiting, and intolerance to solid food were referred
for upper gastrointestinal studies, followed by referral to the
gastroenterologist for upper endoscopy. Patients with
stricture were treated endoscopically with balloon dilation
to a maximum of 15 mm.
Statistical Methods
Patient data were collected prospectively and included
preoperative patient demographics and comorbidities, as
well as postoperative complications extracted to identify
potential influences on stricture rates. Variables included in
the univariate logistic regression analysis are listed in
Table 1.
The SPSS™ software package (version 14.0, SPSS,
Chicago, IL, USA) was used to perform all statistical
analyses. Statistical significance was set at P<0.05. Binary
logistic regression analysis was used in both univariate and
multivariate modeling to identify independent preoperative
variables associated with the development of gastrojejunos-
tomy stricture following LRYGB surgery. Univariate
analysis using logistic regression was applied to identify
significant associations with the dichotomous outcome
variable (stricture). For comparison, Pearson chi-square test
for categorical variables and Student’s t test for continuous
variables were used. A priori preoperative factors of
research interest (P<0.21), as well as those found to be
significantly associated with stricture (P<0.05), were
entered into multivariate analysis using forward stepwise
logistic regression. Likelihood ratio tests were used for
variable selection.
In the initial analysis of preoperative characteristics by
univariate logistic regression, age, number of comorbidities,
number of medications, BMI, fasting blood sugar, HbA1C,
and previous abdominal surgeries were classified as
continuous variables. With the exception of sex and
ethnicity (dichotomized to male/female and Caucasian/
non-Caucasian, respectively), all remaining variables were
dichotomized (yes/no). In the final multivariate forward
stepwise logistic regression model, both age and BMI were
redefined as categorical variables: age was coded to reflect
four levels (≤35, 36 to 45, 46 to 55, and ≥55 years) and
BMI was coded to reflect two levels (<50 and ≥50).
Results
From November 12, 2001, to February 28, 2006
(51 months), 1,351 patients underwent LRYGB at a single
institution. Mean preoperative patient age was 44 years,
mean BMI was 49 kg/m
2, 83% of patients were female, and
mean preoperative weight was 305 lb. Patients were
predominantly Caucasian (89%); 7% were Hispanic; 3%
were African American; and 1% were of Native American,
Asian/Pacific, and other ethnicities.
Operative technique was the same in all procedures,
namely, a retrocolic, retrogastric, transoral, 21-mm, circular
stapled gastrojejunostomy. Mean intraoperative time was
96 min and length of stay averaged 2.8 days; 97.6% of
operations were accomplished laparoscopically and 2.4%
were conversions to open procedures. There were two
reoperations with revision of the gastrojejunostomy in the
“stricture group.” The first was in a patient who developed
a leak immediately postoperatively and returned to the OR
J Gastrointest Surg (2007) 11:403–409 405for definitive management. The patient developed a stricture
thatwasnotamenabletodilationand,at7months,underwent
a revision of her gastrojejunostomy. The second patient had a
stricture that was dilated to 12–15 mm. Subsequent endos-
copy showed no recurrent stricture. She continued to eat very
large portions in multiple meals, developing recurrent
bezoars that had to be cleared endoscopically. The pouch
dilated over time, and even though the gastrojejunostomy
was shown to be only large enough to pass an endoscope, we
were obliged to revise the pouch to a smaller size. Since that
time she has had no further problem with bezoars.
There were no deaths in the stricture group. In the
“nonstricture group,” early mortality was 0.2% (two deaths
<31 days postoperatively); intermediate mortality, 0.3% (four
deaths between 31 and 90 days postoperatively); and late
mortality, 0.4% (five deaths >90 days postoperatively).
Ninety-two patients (6.8%) were diagnosed with stricture
and underwent subsequent endoscopic dilation. Seventeen of
92 stricture patients (18.5%) were on nonsteroidal anti-
inflammatory medications prior to surgery, whereas 294 of
the 1,259 (23.4%) nonstricture patients were on nonsteroidal
anti-inflammatory medications prior to surgery (Table 1). The
difference in stricture rates between these two groups was
not significant.
Our rate of stricture (92/1,351, 6.8%) was in the range of
rates previously reported by Higa et al. (5.3%), Schauer et
al. (4.7%), and DeMaria et al. (6.6%), as compiled by
Perugini
20, at the lower end of the national range of
stricture prevalence. Other complications with the highest
incidence were cholecystectomy (6.5% stricture group vs
3.0% nonstricture group), small bowel obstruction second-
ary to internal hernia (4.4 vs 1.9%), and intra-abdominal
abscess (3.3 vs 2.0%). In the stricture and nonstricture
groups, respectively, leakage occurred in 1.1 and 1.0% of
patients, and port site infection occurred in 2.2 and 3.6% of
patients. Peripheral neuropathy was 5.4% in the stricture
group and 0.5% in the nonstricture group (Table 2).
Mean percent excess weight loss at 1 year following
surgery was the same for both groups (−103.1 lb, 82.6%
stricture group vs −115.8 lb, 82.0% nonstricture group).
Mean numbers of medications were reduced from 4.6 to 1.6
and from 4.2 to 1.5 in the stricture and nonstricture groups,
respectively, at the most recent postoperative examination.
By univariate logistic regression analysis, two preoper-
ative characteristics were identified as factors associated
significantly (P<0.05 level) with stricture: gastroesophage-
al reflux disease (GERD) (P=0.035) and age (P=0.039)
(Table 1). In addition to GERD and age, BMI (P=0.202)
and gender (P=0.208) were incorporated into the final
multivariate analysis. In the first multivariate model
(Table 3), with age defined as a continuous variable,
forward stepwise multivariate logistic regression confirmed
GERD (P=0.006, OR=1.917, CI=1.200–3.062) and age
(P=0.010, OR=0.973, CI=0.953–0.993) to be independent
factors associated with stricture. Seventy-two percent of all
stricture patients were diagnosed with GERD prior to
surgery, and the mean age was 41 years, whereas, in the
preoperative nonstricture group, 57% were diagnosed with
GERD and the mean age was 44 years.
In the second multivariate model (Table 3), age was
classified as a categorical variable to refine our understand-
ing of the impact of age on stricture. Using age group 1
(≤35 years) as the reference category, age groups 2 (36–
45 years) and 3 (46–55 years) were significant at the 0.05
level [group 2, P=0.015 (OR=0.508, CI=0.294–0.877); group
3, P=0.004 (OR=0.431, CI=0.244–0.760)]. GERD remained
significant (P=0.005; OR=1.963, CI=1.227–3.141).
Three postoperative complications were found to be
associated significantly with the presence of stricture by
univariate logistic regression, including readmissions within
30 days of surgery (P=0.000), peripheral neuropathy (P=
0.000), and pneumonia (P=0.031). The postoperative
multivariate model determined readmissions within 30 days
of surgery (P=0.000, OR=4.381, CI=2.666–7.197) and
peripheral neuropathy (P=0.000, OR=11.979, CI=3.423–
41.929) to be statistically significant covariates of stricture.
Decreasing our rate of stricture by a protocol change to
oversewing the gastrojejunostomy with polyglactin was
Table 2 Forward Stepwise Multivariate Logistic Regression Model for Complications of Stricture
Variable Rate, N (%) P Value Odds Ratio (95% Confidence Interval)
Stricture Group Nonstricture Group
30-day readmission 27 (29.35%) 109 (8.66%) 0.000
a 4.381 (2.666–7.197)
Cholecystectomy 6 (6.52%) 38 (3.02%) 0.181 NS
Internal hernia 1 (1.09%) 35 (2.78%) 0.337 NS
Small bowel obstruction 4 (4.35%) 24 (1.91%) 0.500 NS
Intra-abdominal abscess 3 (3.26%) 25 (1.99%) 0.691 NS
Peripheral neuropathy 5 (5.43%) 6 (0.48%) 0.000
a 11.979 (3.423–41.929)
Infection 2 (2.17%) 2 (3.57%) 0.151 NS
aSignificance at the 0.05 level
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with the rate of 6.8% diminishing to 2.8% (P=0.028, OR=
0.358, CI=0.143–0.895). The second protocol adjustment,
administration of an H2 antagonist (prevacid) postopera-
tively, had no effect.
Discussion
Strictures contribute to almost half of all readmissions in
the early perioperative period and require instrumentation
and rehydration. They can also be associated with the
development of a more serious complication, peripheral
neuropathy, as is demonstrated by these data.
Specific intraoperative factors (e.g., surgeon experience)
associated with stricture have been identified as causal by
prior studies. Isolating preoperative factors that may be
causally related to stricture may aid in minimizing this
complication. In their study, Perugini et al. showed
preoperative hypertension and obstructive sleep apnea to
be predictive of complications in general; yet, they
cautioned that their findings might have been confounded
by their high rate of stricture.
20 By logistic regression
analysis, our study found the variables of GERD and age to
be significantly associated with a complication with one of
the highest incidences—stricture. Our results are supportive
of Perugini’s findings, in that we did not find the same
preoperative predictors of complications (hypertension,
obstructive sleep apnea) significantly associated with
stricture and the overall rate was significantly less.
The odds of developing stricture in patients with
preoperative GERD were found to be nearly two times
higher than those for patients without GERD. GERD is a
known inflammatory condition of the upper gastrointestinal
tract that specifically affects the lower esophagus and
fundus. If present, this inflammation may predispose
patients to more vigorous scarring of the gastrojejunostomy.
During the period of the study, we began testing patients
preoperatively for H. pylori. Patients who tested positive
were treated preoperatively. In general, the micropouch
used to create the gastrojejunostomy has been assumed to
be almost devoid of acid-producing cells, and the rate of
ulceration at the anastomosis at the time of endoscopy is
low. It is clear, though, that adding H2 antagonists for
30 days following surgery helps to decrease inflammation,
and in addition, the polyglactin stitch may be less
inflammatory in nature. Data were insufficient at study
summary to demonstrate the statistical significance of
administering H2 antagonists; however, we are encouraged
by the trend of fewer strictures.
Finding that younger rather than older age was associated
with the development of stricture seems clinically counterin-
tuitive.Onereasonforthisisthatageaffectsthesmallvessels’
ability to provide necessary oxygenation to the anastomosis,
and older patients are more likely overall to have diminished
capabilitytooxygenate.Inourcenter,maintenanceonoxygen
the night of surgery is standard; patients who require
continuous positive airway pressure are started in the
anesthesiarecoveryunitandarekeptonsupplementaloxygen
until they can oxygenate in ambulating and resting modes at
greater than 92%. However, as stated, in our first multivariate
model, older age was shown to be slightly protective with
respect to stricture. In the second multivariate model,
designed to refine the interpretation of age effects on
stricture, we found that the odds of developing stricture in
those 35 years or younger were two times greater than those
aged 36–45 years, and 2.32 times greater than those aged
46–55 years. The trend of age being protective against
stricture leveled off and was not significant in those older
than 55 years. More study of this finding is indicated.
Our original assumption that higher rates of central fat
distribution in males might place greater tension on the
Table 3 Significance and
Odds Ratios for Age, GERD,
Gender, and BMI in Multivar-
iate Models to Predict Stricture
aAge classified as a continuous
variable
bSignificant at the 0.05 level
cAge classified as a categorical
variable
Variable P Value Odds Ratio (95% Confidence Interval)
Multivariate model #1
a
Age 0.010
b 0.973 (0.953–0.993)
GERD 0.006
b 1.917 (1.200–3.062)
Gender 0.324 NS
Preoperative BMI 0.086 NS
Multivariate model #2
c
Age overall 0.015
Group 1: ≤35 years (reference category) 1
Group 2: 36–45 years 0.015 0.508 (0.294–0.877)
Group 3: 46–55 years 0.004 0.431 (0.244–0.760)
Group 4: >55 years 0.126 0.596 (0.308–1.156)
GERD 0.005 1.963 (1.227–3.141)
Gender 0.353 NS
Preoperative BMI 0.100 NS
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with higher BMIs, toward stricture, may be in error. The
effect of increased central fat on the anastomosis may not
be injurious if meticulous technique is used to ensure a
tension-free anastomosis. Also, the ischemic effects of
diabetes, sleep apnea, and chronic respiratory disease at
the gastrojejunostomy site may be insufficient, in them-
selves, to cause stricture.
It has been well documented that operative technique
can contribute to increased stricture rates. Previous studies
have reported fewer strictures with hand-sewn anastomoses
than with stapled ones. Some authors have demonstrated
that the 25-mm EEA stapler may be associated with fewer
strictures that the 21-mm EEA stapler; we have a 6.8%
stricture rate with the 21-mm EEA stapler. Further studies
of stapling methodologies are warranted.
It has been proposed that stricture rates may be lessened
by the creation of a larger gastrojejunostomy anastomosis.
The effect on the restrictive element of the bypass and
subsequent effect on weight loss long term has not been
evaluated. We avoided excessive dilation to allow the
patient to maintain as much restriction as possible. Using a
protocol of minimal dilation to between 12.5 and 15 mm
resulted in only one perforation and acceptable weight loss.
In our study and those of others,
21,22 weight loss at 1 year is
not hindered by dilation.
A limitation of this study is that is was retrospective. A
prospective trial in which comorbidities were not controlled
would not be feasible, although a prospective trial of H2
antagonists may be of value. It is difficult to discern the
effect of absorbable suture on stricture rates vs the effect of
H2 antagonists as their introduction to the protocol occurred
in close proximity. The finding that readmissions within
30 days of surgery and postoperative peripheral neuropathy
were statistically significant covariates of stricture most
likely relates to the frequency of readmissions for periph-
eral neuropathy secondary to vitamin deficiencies following
bariatric surgery.
The objective of this study was to reach back in the causal
continuum, prior to the intraoperative effects of technique
and surgeon experience, to identify other potentially salient
contributorstopostoperativestricture.Thisanalysisofalarge
series of patients undergoing RYGB identified GERD and
age as factors associated with gastrojejunostomy stricture.
Conclusions
Using absorbable suture at the gastrojejunostomy anasto-
mosis appears to decrease stricture rates. As identified via
multivariate logistic regression analysis, GERD and age are
independent predictors of gastrojejunostomy stricture.
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